Overview
FTRE market data
Price History
FTRE price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$10.81 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.97 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -3.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $6.89 – $21.39 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.8B · P/B 2.83 · P/S 0.67.
Company News
TD Cowen Maintains Buy on Fortrea Holdings, Raises Price Target to $23Benzinga · Aug 4, 2026, 4:33 PM
Citigroup Maintains Buy on Fortrea Holdings, Raises Price Target to $22Benzinga · Jul 31, 2026, 8:11 PM
Truist Securities Maintains Buy on Fortrea Holdings, Raises Price Target to $26Benzinga · Jul 30, 2026, 3:12 PM
Evercore ISI Group Maintains Outperform on Fortrea Holdings, Raises Price Target to $25Benzinga · Jul 30, 2026, 2:43 PM
Barclays Maintains Equal-Weight on Fortrea Holdings, Raises Price Target to $22Benzinga · Jul 30, 2026, 10:45 AM
8-K filing — Fortrea Holdings Inc. (FTRE)SEC EDGAR · Jul 29, 2026, 10:36 AM
Fortrea Holdings Q2 Adj. EPS $0.23 Beats $0.18 Estimate, Sales $678.200M Beat $647.465M EstimateBenzinga · Jul 29, 2026, 10:30 AM
Fortrea Holdings Raises FY2026 Sales Guidance from $2.550B-$2.650B to $2.620B-$2.690B vs $2.607B EstBenzinga · Jul 29, 2026, 10:29 AM
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate GrowthGlobenewswire Inc · Jul 15, 2026, 11:15 AM
Mizuho Maintains Neutral on Fortrea Holdings, Raises Price Target to $16Benzinga · Jul 13, 2026, 12:14 PM